Astellas Buys Iveric Bio for $5.9 Billion to Bolster Ophthalmology Portfolio

Published on : Published by : Mark Terry

Astellas Buys Iveric Bio for $5.9 Billion to Bolster Ophthalmology Portfolio By Mark TerryMay 2, 2023 Tokyo-based Astellas Pharma is buying Parsippany, NJ’s Iveric Bio for $5.9 billion. Iveric Bio [….]

Maryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO

William Hearl - CEO, Chairman of the Board, and Founder of Immunic Therapeutics
Published on : Published by : Steven Surdez

Maryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO Immunomic Therapeutics Incorporated (ITI), located in Rockville, Maryland recently announced it had closed on $61.3M in financing, exceeding its initial fundraising [….]